US 9789184
Anti-EGFR antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9789184 (Anti-EGFR antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K39/39558